Synthesis, Antiproliferative Activity, 3D-QSAR and Molecular Docking Study of Novel Longifolene-Derived Tetraline Fused N-Acyl-pyrazole Compounds

doi:10.6023/cjoc202312015

Chinese Journal of Organic Chemistry ›› 2024, Vol. 44 ›› Issue (6): 1967-1977.DOI: 10.6023/cjoc202312015 Previous Articles Next Articles

ARTICLES

新型长叶烯基萘满并N-酰基吡唑化合物的合成、抗增殖活性、三维定量构效关系及分子对接研究

秦丽清^a^,^b, 林桂汕^a^,^b^,^*(), 段文贵^a^,^b^,^*(), 崔玉成^a^,^b, 杨卯芳^a^,^b, 李芳耀^c, 李典鹏^d

a 广西大学化学化工学院南宁 530004
b 广西高校应用化学技术与资源开发重点实验室南宁 530004
c 桂林医学院药学院广西桂林 541100
d 广西植物功能物质与资源持续利用重点实验室广西桂林 541006

收稿日期:2023-12-16 修回日期:2024-01-23 发布日期:2024-02-27
基金资助:
国家自然科学基金(32260366); 国家自然科学基金(32360360); 广西植物功能物质研究与利用重点实验室基金(FPRU2020-3)

Synthesis, Antiproliferative Activity, 3D-QSAR and Molecular Docking Study of Novel Longifolene-Derived Tetraline Fused N-Acyl-pyrazole Compounds

Liqing Qin^a^,^b, Guishan Lin^a^,^b,*(), Wengui Duan^a^,^b,*(), Yucheng Cui^a^,^b, Maofang Yang^a^,^b, Fangyao Li^c, Dianpeng Li^d

a School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004
b Guangxi Colleges and Universities Key Laboratory of Applied Chemistry Technology and Resource Development, Nanning 530004
c College of Pharmacy, Guilin Medical University, Guilin, Guangxi 541100
d Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guilin, Guangxi 541006

Received:2023-12-16 Revised:2024-01-23 Published:2024-02-27
Contact: * E-mail: gslin@gxu.edu.cn; wgduan@gxu.edu.cn
Supported by:
National Natural Science Foundation of China(32260366); National Natural Science Foundation of China(32360360); Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization(FPRU2020-3)

1. .pdf(7415KB)

Abstract

In search of novel anticancer drugs, twenty-one novel longifolene-derived tetraline fused N-acylpyrazole compounds 6a~6u were designed and synthesized from renewable natural product longifolene. Their structures were characterized by FT-IR, NMR, HRMS, and X-ray single-crystal diffraction. The in vitro antiproliferative activity of the target compounds was evaluated by the methylthiazolyldiphenyl-tetrazolium bromide (MTT) method. As a result, some of the target compounds showed better antiproliferative activity than that of the positive control fluorouracil (5-FU). Among these, 4-(7-isopropyl-5,5-dimethyl-4,5-dihydro-2H-benzo[g]indazole-2-carbonyl)benzonitrile (6r) (R=p-CNC₆H₄) had IC₅₀ of 4.97 μmol/L against SW480 cell (human colon cancer cell), and (7-isopropyl-5,5-dimethyl-4,5-dihydro-2H-benzo[g]indazol-2-yl)-(4-nitrophenyl) methanone (6q) (R=p-NO₂C₆H₄) had IC₅₀ of 8.02 μmol/L against MCF-7 cell (human breast cancer cell), exhibiting significant antiproliferative activity. Compound 6q (R=p-NO₂C₆H₄) displayed good and broad-spectrum antiproliferative activity, with IC₅₀ of 10.97, 11.95, 19.78, 20.15 and 23.45 μmol/L against MCF-7 cell, MGC-803 cell (human gastric cancer cell line), HepG2 cell (human hepatocellular carcinoma cell), Hela cell (human cervical cancer cell), and A549 cell (human lung adenocarcinoma cell), respectively. Furthermore, the relationship between structures and their antiproliferative activity was investigated by the established 3D-quantitative structure-activity relationship (3D-QSAR) model (r²=0.986 and q²=0.631), and the interaction mode between the target compounds and Survivin was also simulated by molecular docking.

Key words: longifolene-derived tetraline, N-acyl-pyrazole, synthesis, antiproliferative activity, 3D-quantitative structure- activity relationship (3D-QSAR), molecular docking

Cite this article

Liqing Qin, Guishan Lin, Wengui Duan, Yucheng Cui, Maofang Yang, Fangyao Li, Dianpeng Li. Synthesis, Antiproliferative Activity, 3D-QSAR and Molecular Docking Study of Novel Longifolene-Derived Tetraline Fused N-Acyl-pyrazole Compounds[J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 1967-1977.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

Fig. & Tab. 12

References 29

[1]	Kocarnik, J. M.; Compton, K.; Dean, F. E.; Fu, W. J.; Gaw, B. L.; Harvey, J. D.; Henrikson, H. J.; Lu, D.; Pennini, A.; Xu, R. X.; Ababneh, E.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Elsalam, S. M.; Abdoli, A.; Abedi, A.; Abidi, H.; Abolhassani, H.; Adedeji, I. A.; Adnani, Q. E. S.; Advani, S. M.; Afzal, M. S.; Aghaali, M.; Ahinkorah, B. O.; Ahmad, S.; Ahmad, T.; Ahmadi, A.; Ahmadi, S.; Rashid, T. A.; Salih, Y. A.; Akalu, G. T.; Aklilu, A.; Akram, T.; Akunna, C. J.; Hamad, H. A.; Alahdab, F.; Al-Aly, Z.; Ali, S.; Alimohamadi, Y.; Alipour, V.; Aljunid, S. M.; Alkhayyat, M.; Almasi-Hashiani, A.; Almasri, N. A.; Al-Maweri, S. A. A.; Almustanyir, S.; Alonso, N.; Alvis-Guzman, N.; Amu, H.; Anbesu, E. W.; Ancuceanu, R.; Ansari, F.; Ansari-Moghaddam, A.; Antwi, M. H.; Anvari, D.; Anyasodor, A. E.; Aqeel, M.; Arabloo, J.; Arab-Zozani, M.; Aremu, O.; Ariffin, H.; Aripov, T.; Arshad, M.; Artaman, A.; Arulappan, J.; Asemi, Z.; Jafarabadi, M. A.; Ashraf, T.; Atorkey, P.; Aujayeb, A.; Ausloos, M.; Awedew, A. F.; Quintanilla, B. P. A.; Ayenew, T.; Azab, M. A.; Azadnajafabad, S.; Jafari, A. A.; Azarian, G.; Azzam, A. Y.; Badiye, A. D.; Bahadory, S.; Baig, A. A.; Baker, J. L.; Balakrishnan, S.; Banach, M.; Bärnighausen, T. W.; Barone-Adesi, F.; Barra, F. Jama Oncol. 2022, 8, 420.
[2]	Ruiz-Ceamanos, A.; Spence, C.; Navarra, J. Nutr. Cancer 2022, 74, 1927.
[3]	Shah, Z.; Gohar, U. F.; Jamshed, I.; Mushtaq, A.; Mukhtar, H.; Zia-Ui-Haq, M.; Toma, S. I.; Manea, R.; Moga, M.; Popovici, B. Biomolecules 2021, 11, 603.
[4]	Jin, L.; Song, Z. J.; Cai, F.; Ruan, L. J.; Jiang, R. W. Molecules 2022, 28, 302.
[5]	Yin, M.; Fang, Y. S.; Sun, X. T.; Xue, M. G.; Zhang, C. M.; Zhu, Z. Y.; Meng, Y. M.; Kong, L. M.; Myint, Y. Y.; Li, Y.; Zhao, J. F.; Yang, X. D. Front. Chem. 2023, 11, 1191498.
[6]	Liang, X. X.; Wu, Q.; Luan, S. X.; Yin, Z. Q.; He, C. L.; Yin, L. Z.; Zou, Y. F.; Yuan, Z. X.; Li, L. X.; Song, X.; He, M.; Lv, C.; Zhang, W. Eur. J. Med. Chem. 2019, 171, 129.
[7]	Ueno, T.; Uehara, S.; Nakahata, K.; Okuyama, H. Int. J. Oncol. 2016, 48, 1847.
[8]	Glaros, T. G.; Stockwin, L. H.; Mullendore, M. E.; Smith, B.; Morrison, B. L.; Newton, D. L. Cancer Chemother. Pharmacol. 2012, 70, 207.
[9]	Karrouchi, K.; Radi, S.; Ramli, Y.; Taoufik, J.; Mabkhot, Y.; Al-aizari, F.; Ansar, M. H. Molecules 2018, 23, 134.
[10]	Bennani, F. E.; Doudach, L.; Cherrah, Y.; Ramli, Y.; Karrouchi, K.; Ansar, M. H.; Faouzi, M. E. A. Bioorg. Chem. 2020, 97, 103470.
[11]	Zhang, Y. Q.; Wu, C. Y.; Zhang, N. N.; Fan, R.; Ye, Y.; Xu, J. Int. J. Mol. Sci. 2023, 24, 12724.
[12]	Wang, M.; Xu, S.; Lei, H. J.; Wang, C. L.; Xiao, Z.; Jia, S.; Zhi, J.; Zheng, P. W.; Zhu, W. F. Bioorg. Med. Chem. 2017, 25, 5754
[13]	Payne, M.; Bottomley, A. L.; Och, A.; Asmara, A. P.; Harry, E. J.; Ung, A. T. Biorg. Med. Chem. 2021, 48, 116401.
[14]	Karati, D.; Mahadik, K. R.; Kumar, D. Med. Chem. 2022, 18, 1060.
[15]	Kumar, G.; Krishna, V. Siva.; Sriram, D.; Jachak, S. M. Arch. Pharm. 2020, 353, 2000077.
[16]	Maciejewska, N.; Olszewski, M.; Jurasz, J.; Serocki, M.; Dzier- zynska, M.; Cekala, K.; Wieczerzak, E.; Baginski, M. Sci. Rep. 2022, 12, 3703. doi: 10.1038/s41598-022-07691-6 pmid: 35260633
[17]	Gomha, S. M.; Edrees, M. M.; Faty, R. A. M.; Muhammad, Z. A.; Mabkhot, Y. N. BMC Chem. 2017, 11, 37.
[18]	Min, Z. L.; Zhu, Y.; Hong, X.; Yu, Z. J; Ye, M.; Yuan, Q.; Hu, X. M. Drug Des., Dev. Ther. 2020, 14, 2517.
[19]	Kang, M.; Pandit, N.; Kim, A. Y.; Cho, S. J.; Kwon, Y. J.; Ahn, J.; Lee, K. M.; Wu, S.; Oh, J. S.; Jung, K. Y.; Kim, J. S. Front. Oncol. 2022, 12, 835833.
[20]	Romagnoli, R.; Oliva, P.; Salvador, M. K.; Camacho, M. E.; Padroni, C.; Brancale, A.; Ferla, S.; Hamel, E.; Ronca, R.; Grillo, E.; Bortolozzi, R.; Rruga, F.; Mariotto, E.; Viola, G. Eur. J. Med. Chem. 2019, 181, 111577.
[21]	Shaikh, J.; Patel, K.; Khan, T. Mini-Rev. Med. Chem. 2022, 22, 1197.
[22]	Feng, J. J.; Qi, H.; Sun, X. Y.; Feng, S.; Liu, Z. M.; Song, Y. L.; Qiao, X. Q. Chem. Pharm. Bull. 2018, 66, 1065
[23]	Shaker, A. M. M.; Shahin, M. I.; AboulMagd, A. M.; Abdel Aleem, S. A.; Abdel-Rahman, H. M.; Abou El Ella, D. A. Bioorg. Chem. 2022, 129, 106143.
[24]	Min, D.; Zhao, J.; Chen, Y.; Zhao, Z. D. Biomass Chem. Eng. 2017, 51, 54.
[25]	Lan, H. L.; Zhu, X. P.; Lin, G. S.; Duan, W. G.; Cui, Y. C.; Li, F. Y.; Li, D. P. Chem. Biodiversity 2023, 20, e202201163.
[26]	Zhu, X. P.; Lin, G. S.; Duan, W. G.; Li, Q. M.; Li, F. Y.; Lu, S. Z. Molecules 2020, 25, 986.
[27]	Li, Q. M.; Lin, G. S.; Duan, W. G.; Cui, Y. C.; Li, F. Y.; Lei, F. H.; Li, D. P. New J. Chem. 2022, 46, 8688.
[28]	Cui, Y. C.; Chen, M. H; Lin, G. S.; Duan, W. G.; Li, Q. M.; Zou, R. X.; Ceng, B. Chin. J. Org. Chem. 2022, 42, 3784. (in Chinese)
	(崔玉成, 陈美桦, 林桂汕, 段文贵, 李晴敏, 邹壬萱, 岑波, 有机化学, 2022, 42, 3784.) doi: 10.6023/cjoc202204055
[29]	BoEl-Zoghbi, M. S.; El-Sebaey, S. A.; Al-Ghulikah, H. A.; Sobh, E. A. J. Enzyme Inhib. Med. Chem. 2023, 38, 2175209.

Compd.	IC₅₀^a/(μmol•L^–1)
Compd.	MCF-7	SW480	Hela
6a	>100	78.62±0.23	>100
6b	58.64±0.22	>100	>100
6c	25.60±1.09	>100	>100
6d	57.43±0.14	>100	68.95±0.15
6e	23.47±0.24	49.93±0.20	>100
6f	32.02±0.16	26.10±0.45	>100
6g	44.40±0.58	>100	>100
6h	31.63±2.05	41.32±0.23	>100
6i	27.19±0.24	69.78±0.08	25.43±4.03
6j	37.37±0.88	>100	>100
6k	22.62±0.19	29.28±0.98	>100
6l	22.72±0.23	28.06±0.64	33.86±0.32
6m	20.40±0.21	19.84±0.69	36.46±0.32
6n	13.38±0.35	23.69±1.16	14.68±0.28
6o	32.01±1.43	25.73±1.14	>100
6p	14.45±0.36	24.35±1.56	32.20±0.33
6q	10.92±0.49	8.02±0.39	20.15±1.47
6r	4.97±0.21	18.77±0.09	>100
6s	>100	49.75±0.11	>100
6t	>100	>100	>100
6u	47.55±3.64	61.67±0.09	>100
5-FU^b	27.05±1.85	13.72±0.21	23.07±0.99

Compd.	IC₅₀^a/(μmol•L^–1)
Compd.	MCF-7	SW480	Hela
6a	>100	78.62±0.23	>100
6b	58.64±0.22	>100	>100
6c	25.60±1.09	>100	>100
6d	57.43±0.14	>100	68.95±0.15
6e	23.47±0.24	49.93±0.20	>100
6f	32.02±0.16	26.10±0.45	>100
6g	44.40±0.58	>100	>100
6h	31.63±2.05	41.32±0.23	>100
6i	27.19±0.24	69.78±0.08	25.43±4.03
6j	37.37±0.88	>100	>100
6k	22.62±0.19	29.28±0.98	>100
6l	22.72±0.23	28.06±0.64	33.86±0.32
6m	20.40±0.21	19.84±0.69	36.46±0.32
6n	13.38±0.35	23.69±1.16	14.68±0.28
6o	32.01±1.43	25.73±1.14	>100
6p	14.45±0.36	24.35±1.56	32.20±0.33
6q	10.92±0.49	8.02±0.39	20.15±1.47
6r	4.97±0.21	18.77±0.09	>100
6s	>100	49.75±0.11	>100
6t	>100	>100	>100
6u	47.55±3.64	61.67±0.09	>100
5-FU^b	27.05±1.85	13.72±0.21	23.07±0.99

Compd.	Dipole moment^a/D	The electrostatic potential of benzene ring center^a/(kJ•mol^–1)
6h	5.06	–38.01
6r	5.17	17.79
6q	5.37	26.45

Compd.	Dipole moment^a/D	The electrostatic potential of benzene ring center^a/(kJ•mol^–1)
6h	5.06	–38.01
6r	5.17	17.79
6q	5.37	26.45

Compd.	IC₅₀^a/(μmol•L^–1)
Compd.	A549	HepG2	MGC-803
6m	13.70±0.61	37.98±3.41	18.98±2.06
6n	41.05±2.31	12.02±1.08	15.14±0.67
6p	30.91±2.90	27.78±4.21	25.90±3.37
6q	23.45±0.99	19.78±0.79	11.95±0.71
6r	28.98±0.72	22.89±1.22	9.83±0.19
5-FU^b	31.41±0.41	26.56±1.25	14.55±1.24

新型长叶烯基萘满并N-酰基吡唑化合物的合成、抗增殖活性、三维定量构效关系及分子对接研究

Synthesis, Antiproliferative Activity, 3D-QSAR and Molecular Docking Study of Novel Longifolene-Derived Tetraline Fused N-Acyl-pyrazole Compounds

RichHTML

PDF

Supporting Info.

Knowledge

Abstract

Cite this article

share this article

Fig. & Tab. 12

References 29

Related Articles 15

Recommended Articles

Metrics

Comments

Compd.	pIC₅₀	CoMFA	pIC₅₀"	Residue
6a	3.996	166	3.982	0.014
6b	4.232	162	4.238	0.006
6c*	4.592	156	4.601	0.009
6d*	4.241	158	4.299	–0.058
6e	4.629	160	4.634	–0.005
6f	4.495	160	4.479	0.016
6g	4.353	156	4.347	0.006
6h	4.500	162	4.469	0.031
6i	4.566	152	4.598	–0.032
6j	4.427	158	4.529	–0.102
6k	4.646	158	4.667	–0.021
6l	4.644	154	4.640	0.004
6m	4.690	158	4.630	0.06
6n	4.874	156	4.864	0.01
6o	4.495	154	4.478	0.017
6p	4.840	156	4.821	0.019
6q	4.961	166	4.996	–0.035
6r	5.304	158	5.282	0.022

[1]	Jianling Hu, Chao Zhang, Wenda Zhu, Yepu He, Shuling Peng, Zhenqiang Chen, Mingyue Li, Zhiju Liu, Heru Chen. Design, Synthesis, and Preliminary Anti-tumor Activity Studies of Novel 1,2-Disubstituted Hydrazines [J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 1870-1883.
[2]	Leilei Liang, Jiacan Yao, Fan Ding, Chang Xu, Dandan Liu. Research Progress on the Synthetic Methods of Pancratistatin [J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 1793-1810.
[3]	Guochao Liang, Tingting Dong, Haiying Ji, Chunyan Wang, Yali Song, Wei Zhang. Synthesis and Antitumor Activity of Novel 3,3'-((4-Chloro-2H-thiochromen-3-yl)methylene)bis(1H-indole)-Like Topoisomerase II Inhibitors [J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 1949-1956.
[4]	Yiming Hu, Jiayu Xu, Min Tang, Yawen Liu, Liping Guan, Qinghao Jin. Design, Synthesis and Biological Activity Studies of 2-(1,3-Dioxoiso-indolin-2-yl)-N-phenethylacetamide and 2-(3,4-Dihydroisoquinolin-1-yl)isoindole-1,3-dione as Monoamine Oxidase (MAO) and Cholinesterase (ChE) Inhibitors [J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 1907-1919.
[5]	Lingdong Li, Weilun Zhang, Pengfei Liu, Zijie Zhou, Hao Zhou, Zhongtian Du. Synthesis of Gemini-Quaternary Ammonium N-Chloramine Biocides for Antibacterial Applications [J]. Chinese Journal of Organic Chemistry, 2024, 44(6): 2041-2048.
[6]	Yiping Sun, Demao Chen, Ling He, Zuli Wang. Na₂S₂O₈ Mediated C—H Amination of Imidazo[1,2-α]pyridines with Heteroaromatic Amines under Metal-Free Conditions [J]. Chinese Journal of Organic Chemistry, 2024, 44(5): 1667-1674.
[7]	Jiyong Liu, Minghui Wu, Juncheng Xiang, Huailin Pang, Bin Li, Liang Lü. Synthesis, Insecticidal Activities, and Structure-Activity Relationship Studies of Novel Diamide Compounds Containing (Halogenated) Alkoxy Group [J]. Chinese Journal of Organic Chemistry, 2024, 44(5): 1584-1591.
[8]	Hongyan Pei, Jialin Ye, Feng Wang, Dongdong Liu, Yukui Yu, Jing Zhang, Lixin Zhang. Design, Synthesis and Herbicidal Activity of Novel Uracil Compounds Containing Piperidine Moiety [J]. Chinese Journal of Organic Chemistry, 2024, 44(5): 1592-1605.
[9]	Qinfang Xu, Jianling Hu, Yuanlin Liu, Chao Zhang, Mingyue Li, Shuling Peng, Zhijun Liu, Heru Chen. Design, Syntheses of Novel Triazenes with Better Druggability and the Investigation on Their Anti-tumor Activities [J]. Chinese Journal of Organic Chemistry, 2024, 44(5): 1606-1619.
[10]	Wensheng Zhang, Wei Zheng, Guoqiang Zuo, Keyou Ma, Hequan Xiao, Gaiyun Liu. One-Pot Reductive Amination/N-Acylation/Aza-Wittig Reaction for the Synthesis of 3,4-Dihydroquinazolines [J]. Chinese Journal of Organic Chemistry, 2024, 44(5): 1686-1690.
[11]	Xiao Zhang, Mixia Hu, Yanqing Du, Fengying Liang, Xiaoying Zhang, Chaolu Eerdun. Research Progress on Anion-π Interactions [J]. Chinese Journal of Organic Chemistry, 2024, 44(4): 1181-1196.
[12]	Tianfeng Peng, Yuxiang Zhao, Shaojian Pu, Juan Luo, Teng Liu, Yingchun Miao, Xianfu Shen. Recent Advances in Total Synthesis of Prenylated Indole Alkaloids by Transition Metal-Catalyzed Reactions as the Key Step [J]. Chinese Journal of Organic Chemistry, 2024, 44(4): 1160-1180.
[13]	Hao Ye, Haibin Zhang, Ya'nan Wu, Xinxing Wu. Research Progress in the Synthesis of Azaindoline and Its Derivatives [J]. Chinese Journal of Organic Chemistry, 2024, 44(4): 1106-1123.
[14]	Youjin Wu, Zhengsheng Jin, Yongjia Liu, Wenqian Huang, Guilong Zhao. Design, Synthesis and Bioactivity of NYX-2925 L-Proline Derivatives as N-Methyl-D-aspartate (NMDA) Receptor Partial Agonists [J]. Chinese Journal of Organic Chemistry, 2024, 44(4): 1247-1263.
[15]	Linheng He, Wen Xia, Yuxiang Zhou, Xianyong Yu. Electrocatalysis Decarboxylative Annulation of Benzol[e][1,2,3]-oxathiazine-2,2-dioxides with N-Arylglycines [J]. Chinese Journal of Organic Chemistry, 2024, 44(3): 997-1004.

q²	r²	S	F	Contribution/%
q²	r²	S	F	Steric	Electrostatic
0.631	0.986	0.046	107.042	42.7	57.3

q²	r²	S	F	Contribution/%
q²	r²	S	F	Steric	Electrostatic
0.631	0.986	0.046	107.042	42.7	57.3